Cargando…

Multiple drugs: COVID-19 infection: 5 case reports

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184338/
http://dx.doi.org/10.1007/s40278-022-17141-z
_version_ 1784724491891376128
collection PubMed
description
format Online
Article
Text
id pubmed-9184338
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-91843382022-06-10 Multiple drugs: COVID-19 infection: 5 case reports Reactions Weekly Case Report Springer International Publishing 2022-06-11 2022 /pmc/articles/PMC9184338/ http://dx.doi.org/10.1007/s40278-022-17141-z Text en © Springer International Publishing AG 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Case Report
Multiple drugs: COVID-19 infection: 5 case reports
title Multiple drugs: COVID-19 infection: 5 case reports
title_full Multiple drugs: COVID-19 infection: 5 case reports
title_fullStr Multiple drugs: COVID-19 infection: 5 case reports
title_full_unstemmed Multiple drugs: COVID-19 infection: 5 case reports
title_short Multiple drugs: COVID-19 infection: 5 case reports
title_sort multiple drugs: covid-19 infection: 5 case reports
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184338/
http://dx.doi.org/10.1007/s40278-022-17141-z